Literature DB >> 21880334

Sleep-wake changes in the premotor stage of Parkinson disease.

Alex Iranzo1.   

Abstract

Longitudinal studies in Parkinson disease (PD) have shown that the prevalence of sleep disorders increases with advanced disease. However, two sleep disorders, namely excessive daytime sleepiness (EDS) and REM sleep behavior disorder (RBD) have been described to antedate the development of the classical motor signs and symptoms of PD. One epidemiological study from the Honolulu-Asia Aging Study showed that aging men who reported "being sleepy most of the daily" had a threefold excess risk for developing PD after a seven-year follow-up. The origin and nature of EDS were not investigated. This study needs to be replicated. More robust data exist regarding RBD as the first manifestation of PD. RBD subjects commonly develop parkinsonism and cognitive impairment with time. Patients with the idiopathic form of RBD with decreased striatal dopamine transporters imaging, substantia nigra hyperechogenicity and hyposmia have an increased short-term risk for developing the classical motor, dysautonomic and cognitive symptoms of a synucleinopathy. Patients with idiopathic RBD, particularly those with abnormal subclinical features seen in the synucleinopathies such as decreased striatal dopamine transporters uptake, are the ideal population to be tested with disease-modifying agents in order to stop or slow down neurodegeneration in the brain.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21880334     DOI: 10.1016/j.jns.2011.07.049

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

Review 1.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

2.  Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder.

Authors:  Carolina Aguirre-Mardones; Alex Iranzo; Dolores Vilas; Mónica Serradell; Carles Gaig; Joan Santamaría; Eduardo Tolosa
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

Review 3.  Exploring the Role of Orexinergic Neurons in Parkinson's Disease.

Authors:  Sachin Kumar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harassi; Mohammed M Abdel-Daim; Simona Bungau
Journal:  Neurotox Res       Date:  2021-09-08       Impact factor: 3.911

Review 4.  Perspectives on the rapid eye movement sleep switch in rapid eye movement sleep behavior disorder.

Authors:  Vetrivelan Ramaligam; Michael C Chen; Clifford B Saper; Jun Lu
Journal:  Sleep Med       Date:  2013-06-13       Impact factor: 3.492

5.  Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

Authors:  Joana Meireles; João Massano
Journal:  Front Neurol       Date:  2012-05-25       Impact factor: 4.003

6.  Sleep spindle alterations in patients with Parkinson's disease.

Authors:  Julie A E Christensen; Miki Nikolic; Simon C Warby; Henriette Koch; Marielle Zoetmulder; Rune Frandsen; Keivan K Moghadam; Helge B D Sorensen; Emmanuel Mignot; Poul J Jennum
Journal:  Front Hum Neurosci       Date:  2015-05-01       Impact factor: 3.169

Review 7.  Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person.

Authors:  Christine E Mc Carthy
Journal:  Med Sci (Basel)       Date:  2021-05-21

8.  Sleep disturbance in mental health problems and neurodegenerative disease.

Authors:  Kirstie N Anderson; Andrew J Bradley
Journal:  Nat Sci Sleep       Date:  2013-05-31

9.  α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls.

Authors:  Lynnae M Smith; Mya C Schiess; Mary P Coffey; Andrea C Klaver; David A Loeffler
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

10.  Non-motor symptoms of Parkinson's disease: the patient's perspective.

Authors:  Kieran C Breen; Gerda Drutyte
Journal:  J Neural Transm (Vienna)       Date:  2012-12-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.